TBD | Will Booster Shots Make a Difference?
The Biden administration says a third dose of vaccines for all American adults will end the pandemic faster. And experts say there is evidence of waning vaccine effectiveness against mild-to-moderate disease. But globally, what’s the best use of the next available dose? Guest: Saad Omer, director of the Yale Institute for Global Health. Host: Lizzie O’LearyThis episode was produced by Alyssa Edes. Hosted on Acast. See acast.com/privacy for more information.
20 Elo 202118min
Will Booster Shots Make a Difference?
The Biden administration says a third dose of vaccines for all American adults will end the pandemic faster. And experts say there is evidence of waning vaccine effectiveness against mild-to-moderate disease. But globally, what’s the best use of the next available dose? Guest: Saad Omer, director of the Yale Institute for Global Health. Host: Lizzie O’LearyThis episode was produced by Alyssa Edes. Hosted on Acast. See acast.com/privacy for more information.
20 Elo 202118min
The Afghans Who Couldn’t Get Out
The rapid collapse of the Afghan government has left tens of thousands of people struggling to leave their country. Afghans who helped U.S. forces were promised a life in the states, but many of them have been mired in paperwork as they try to obtain their visas. What hope do they have now that they’ll be able to leave before an expected Taliban crackdown?Guest: Ahmadullah Sediqi of No One Left Behind, a group trying to secure visas for Afghan and Iraqi interpreters who worked for the U.S. If you enjoy this show, please consider signing up for Slate Plus. Slate Plus members get benefits like zero ads on any Slate podcast, bonus episodes of shows like Slow Burn and Dear Prudence—and you’ll be supporting the work we do here on What Next. Sign up now at slate.com/whatnextplus to help support our work. Hosted on Acast. See acast.com/privacy for more information.
19 Elo 202124min
A Texas Standoff
The Texas state legislature is at a standstill. A month ago, House Democrats fled to DC to prevent the passage of a restrictive voting law but as time ticks by it’s becoming clear that they might have to go back to the drawing board -- and back to Texas. Guest: Ashley Lopez, Senior Reporter at KUT Hosted on Acast. See acast.com/privacy for more information.
18 Elo 202120min
How Afghanistan Ended Like This
American forces are leaving Afghanistan after 20 years of fighting the country’s longest war. Following a hasty withdrawal of U.S. forces, the Taliban now controls most of the country, including the capital of Kabul. The U.S.-backed government has fled, leaving many civilians desperate to find a way out. How did things get so bad so quickly?Guest: Fred Kaplan, Slate’s War Stories columnist. Kaplan is the author of The Bomb: Presidents, Generals, and the Secret History of Nuclear War. If you enjoy this show, please consider signing up for Slate Plus. Slate Plus members get benefits like zero ads on any Slate podcast, bonus episodes of shows like Slow Burn and Dear Prudence—and you’ll be supporting the work we do here on What Next. Sign up now at slate.com/whatnextplus to help support our work. Hosted on Acast. See acast.com/privacy for more information.
17 Elo 202123min
Mask Wars and the Start of School in the South
Masks were uncontroversial for many state leaders at the onset of the pandemic last year. But now, masks have become politicized, and in Mississippi, Governor Tate Reeves has reversed his previous stance, refusing to order a mask mandate and leaving local school districts to fend for themselves during a massive surge in COVID cases.Guest: Nick Judin, reporter for the Mississippi Free Press. If you enjoy this show, please consider signing up for Slate Plus. Slate Plus members get benefits like zero ads on any Slate podcast, bonus episodes of shows like Slow Burn and Dear Prudence—and you’ll be supporting the work we do here on What Next. Sign up now at slate.com/whatnextplus to help support our work. Hosted on Acast. See acast.com/privacy for more information.
16 Elo 202123min
TBD | What's Taking the FDA So Long?
Experts say that a “fully approved” designation for the vaccines could have sweeping effects. Broader vaccination mandates, inclusion for new age groups, and reassurance for those hesitant to take a vaccine without the designation. As calls for approval grow louder and more urgent, the Food and Drug Administration is yet to give its blessing. What’s happening inside the FDA as they work toward this milestone?Guest: Sarah Owermohle, health care reporter at Politico Host:Lizzie O’Leary Hosted on Acast. See acast.com/privacy for more information.
13 Elo 202123min
What's Taking the FDA So Long?
Experts say that a “fully approved” designation for the vaccines could have sweeping effects. Broader vaccination mandates, inclusion for new age groups, and reassurance for those hesitant to take a vaccine without the designation. As calls for approval grow louder and more urgent, the Food and Drug Administration is yet to give its blessing. What’s happening inside the FDA as they work toward this milestone?Guest: Sarah Owermohle, health care reporter at Politico Host:Lizzie O’Leary Hosted on Acast. See acast.com/privacy for more information.
13 Elo 202123min
